PROGRAM PREVIEW
EPIC Program Agenda Preview
Confirmed Sessions. Leading Industry Experts. Much More to Come. Including Exhibit Hall Details
Executive Pharma Insights Conference · January 27–28, 2027 · Hanover Marriott Hotel, Whippany, NJ
12 panel discussions with 50+ pharma leaders
Inside the War Room of Pharma Insights Teams
Boehringer Ingelheim · Chugai · Merck · Novartis · Pfizer · Regeneron
Proving the Value of Insights and Analytics Functions to the Business
Bristol Myers Squibb · Eisai · Moderna · Viatris
The Insight Function of the Future — What Gets Automated, and What Never Will
AstraZeneca · Chiesi · CSL Behring · Insmed
Boardroom Discussion: AI in the Insights Function
AstraZeneca · Bayer · Bristol Myers Squibb · Ferring · Novartis · Organon · Sun Pharma
The Forecast, the Research, and the Truth — How Commercial Teams Decide What to Believe
Amicus · AstraZeneca · Chiesi
Evolution and Transformation of Customer Insights: New Data, New Methods, New Ways of Working
NewAmsterdam · Regeneron · Pfizer · Sanofi
Partnering and Licensing Deals — How Insights and Analytics Support Business Development, Not Just Brand Strategy
Bristol Myers Squibb · Genmab · Knoa · Organon
Insight, But Make It Actionable — Bridging the Gap Between “Interesting” and “Useful”
Abbott · Bristol Myers Squibb · Collegium · Merck
Data Overload, Insight Shortage — Why More Data Isn’t Producing Better Decisions
Bristol Myers Squibb · Organon · Pfizer · Regeneron
Forecasting for Brands at Different Lifecycle Stages
AstraZeneca · EMD Serono · Regeneron
Market Research vs. Technology — Lessons Learned
Arcutis · Bayer · Omeza
A Leadership Fireside Chat
AstraZeneca · Boehringer Ingelheim · Merck · Novartis · Organon · Pfizer · Regeneron
ROUNDTABLES
What Makes an Insight Stick? The Neuroscience and Behavioral Science of Getting Research Remembered, Believed, and Acted Upon
Bristol Myers Squibb
The Segmentation That Looked Great on Paper: Why Pharma Segments Fail to Survive Contact With the Real World
EMD Serono
Insights for a Portfolio That Didn’t Exist Five Years Ago
Moderna
The Signals That Move the Forecast: Which Early Market Indicators Really Matter?
Regeneron
From Market Insight to Launch Strategy: What Brand Leaders Really Need Before Launch
Arcutis
Building a Commercial Analytics Function from Scratch
Pharmacosmos Therapeutics Inc.
PRESENTATIONS
From Intelligence to Impact: Translating Complex Market Data into Real-World Pharma Stories
CSL Behring
The ‘Human in the Decision Loop’: Leveraging AI in Scaling Market Intelligence from Early Pipeline to Launch Execution
Arcutis
AI Forecasting: Keeping Control
Sanofi
In pharma forecasting, AI is moving from experimentation toward practical application. This session explores how treating AI much like a junior modeler can create a more effective and controlled model of collaboration.
High Performance in Generics: How Insights Drive Better Decisions
Xttrium
How modern business insights organizations can become early-warning and decision-support functions — helping teams anticipate change rather than simply report on it.
The Future of Insights: A Huge Opportunity to Reinvent Ourselves
What’s already on the program
- AI & the Future of Insights From AI forecasting and market intelligence to the human role in decision-making.
- Forecasting & Decision Making How commercial teams determine what to believe, which signals matter, and how forecasting changes across the product lifecycle.
- Customer & Market Insights New data, new methods and new approaches to making insights actionable.
- Commercial Analytics & Business Impact How insights organizations prove their value, support decisions and influence the business.
- Launch, Portfolio & Business Development From early pipeline through launch, and from brand strategy to licensing and partnering decisions.
- The Future of the Insights Function What gets automated, what doesn’t, and what the next generation of insights organizations will look like.
Who’s already part of the EPIC conversation
This is just the beginning.
The EPIC program is continuing to grow.
More speakers. More sessions. More perspectives. More of the people shaping the future of pharma insights. See who’s speaking.
Register now under favorable early rates.
Stay tuned for the full program agenda.